The DBV Technologies internet site is an ideal place to discover more about this French company’s potentially revolutionary new solution to the diagnosis and treatment of a number of allergies, including cow’s milk protein allergy.
This particular allergy is one of the most widespread of all food allergies, meaning that the quest for a safe milk allergy treatment has always been a priority. Affecting up to 3% of babies and young children, CMPA has a number of unpleasant side-effects, including vomiting and diarrhoea.
Treating young children using traditional immunotherapy methods, such as injections and oral drops, has always been problematic. It’s partially for patients like these that the Viaskin patch (see below), has been developed. As you can see, it’s simply placed directly upon the patient’s skin, typically on the arm. It delivers antigens to the patient through the skin, in a novel and entirely safe fashion, as the allergens are not introduced directly into the bloodstream, as would be the case in other approaches. The patch can be taken off when desired, meaning you can gradually build up the amount of time you expose your body to the antigens in question.